You are here
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
You can narrow down the results using the filters.
- Safety alertsThe TGA is warning consumers against taking EVE branded products that contain allylisopropylacetylurea (apronal) as they pose a significant health risk and are prohibited from sale, supply or use in Australia.
- Medicine shortage alertsThere remains an increased global demand for semaglutide products which is impacting availability and certainty of supply of Ozempic (semaglutide) in Australia until early 2023.
- Medicine shortage alertsBoehringer Ingelheim (BI) has advised the TGA of a shortage of tenecteplase (Metalyse) injection that is predicted to extend over the next 18 months.
- Safety alertsA safety warning has been added to a class of medicines called Janus Kinase inhibitors used for chronic inflammatory conditions.
- Medicine shortage alertsWe continue to monitor antibiotic medicines in shortage and are seeking and prioritising applications for overseas alternatives to assist with supply.
- Joint statement: Prioritisation of semaglutide (Ozempic) supply for people with type 2 diabetes during shortageMedicine shortage alertsJoint statement on the Ozempic (semaglutide) shortage and prioritisation for people with type 2 diabetes.
- Product recallsMedtronic Australasia is informing customers about the serious risk of valve infolding for EvolutePRO+ 34mm Transcatheter Aortic Valve (TAV), item code - EVPROPLUS-34US.
- Medicine shortage alertsTo help manage the shortage of the antibiotic phenoxymethylpenicillin (Penicillin V), we have made a Serious Scarcity Substitution Instrument (SSSI).
- Product recallsBioCeuticals is recalling one Batch 220380 (exp 02/2024) of Ultra Potent-C Chewable (60s) (AUST L 208690) following a consumer report of a metal fragment found in one tablet.
- Medicine shortage alertsA 12-month shelf-life extension is now in place for all batches with an original expiry date from January 2022 to March 2025.
- Medicine shortage alertsAs the shortage of Coumadin 5mg tablets is expected to continue, the TGA has made a Serious Scarcity Substitution Instrument to assist patients to access their medicine from their pharmacist without delay or interruption to treatment.